project id: TCGA-UVM; case submitter id: TCGA-RZ-AB0B; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.7; age at index: 47; days to birth: -17514; days to death: 149; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1966; year of death: 2013; age at diagnosis: 17514; ajcc clinical m: MX; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc pathologic m: M1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C69.80; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of eye and adnexa; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of eye and adnexa; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 126; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-RZ-AB0B-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 97.0;